Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Neurotoxicol Teratol ; 34(1): 1-8, 2012.
Article in English | MEDLINE | ID: mdl-22024239

ABSTRACT

The acute toxicity of organophosphates (OPs) has been studied extensively; however, much less attention has been given to the subject of repeated exposures that are not associated with overt signs of toxicity (i.e., subthreshold exposures). The objective of this study was to determine if the protracted spatial learning impairments we have observed previously after repeated subthreshold exposures to the insecticide chlorpyrifos (CPF) or the alkylphosphate OP, diisopropylfluorophosphate (DFP) persisted for longer periods after exposure. Male Wistar rats (beginning at two months of age) were initially injected subcutaneously with CPF (10.0 or 18.0mg/kg) or DFP (0.25 or 0.75 mg/kg) every other day for 30 days. After an extended OP-free washout period (behavioral testing begun 50 days after the last OP exposure), rats previously exposed to CPF, but not DFP, were impaired in a radial arm maze (RAM) win-shift task as well as a delayed non-match to position procedure. Later experiments (i.e., beginning 140 days after the last OP exposure) revealed impairments in the acquisition of a water maze hidden platform task associated with both OPs. However, only rats previously exposed to DFP were impaired in a second phase of testing when the platform location was changed (indicative of deficits of cognitive flexibility). These results indicate, therefore, that repeated, subthreshold exposures to CPF and DFP may lead to chronic deficits in spatial learning and memory (i.e., long after cholinesterase inhibition has abated) and that insecticide and alkylphosphate-based OPs may have differential effects depending on the cognitive domain evaluated.


Subject(s)
Chlorpyrifos/toxicity , Cholinesterase Inhibitors/toxicity , Isoflurophate/toxicity , Learning Disabilities/chemically induced , Memory Disorders/chemically induced , Animals , Chronic Disease , Disease Models, Animal , Learning Disabilities/diagnosis , Learning Disabilities/physiopathology , Male , Memory Disorders/diagnosis , Memory Disorders/physiopathology , Rats , Rats, Wistar
2.
Neuroscience ; 176: 237-53, 2011 Mar 10.
Article in English | MEDLINE | ID: mdl-21185910

ABSTRACT

Organophosphates (OPs) pose a constant threat to human health due to their widespread use as pesticides and their potential employment in military and terrorist attacks. The acute toxicity of OPs has been extensively studied; however, the consequences of prolonged or repeated exposure to levels of OPs that produce no overt signs of acute toxicity (i.e. subthreshold levels) are poorly understood. Further, there is clinical evidence that such repeated exposures to OPs lead to prolonged deficits in cognition, although the mechanism for this effect is unknown. In this study, the behavioral and neurochemical effects of repeated, intermittent, and subthreshold exposures to the alkyl OP, diisopropylfluorophosphate (DFP) were investigated. Rats were injected with DFP s.c. (dose range, 0.25-1.0 mg/kg) every other day over the course of 30 days, and then given a 2 week, DFP-free washout period. In behavioral experiments conducted at various times during the washout period, dose dependent decrements in a water maze hidden platform task and a spontaneous novel object recognition (NOR) procedure were observed, while prepulse inhibition of the acoustic startle response was unaffected. There were modest decreases in open field locomotor activity and grip strength (particularly during the DFP exposure period); however, rotarod performance and water maze swim speeds were not affected. After washout, DFP concentrations were minimal in plasma and brain, however, cholinesterase inhibition was still detectable in the brain. Moreover, the 1.0 mg/kg dose of DFP was associated with (brain region-dependent) alterations in nerve growth factor-related proteins and cholinergic markers. The results of this prospective animal study thus provide evidence to support two novel hypotheses: (1) that intermittent, subthreshold exposures to alkyl OPs can lead to protracted deficits in specific domains of cognition and (2) that such cognitive deficits may be related to persistent functional changes in brain neurotrophin and cholinergic pathways.


Subject(s)
Brain/drug effects , Cholinesterase Inhibitors/toxicity , Cognition/drug effects , Isoflurophate/toxicity , Nerve Growth Factors/drug effects , Acetylcholine/metabolism , Animals , Behavior, Animal/drug effects , Brain/metabolism , Choline O-Acetyltransferase/metabolism , Cholinesterase Inhibitors/administration & dosage , Cholinesterase Inhibitors/analysis , Immunoblotting , Isoflurophate/administration & dosage , Isoflurophate/analysis , Male , Motor Activity/drug effects , Nerve Growth Factors/metabolism , Rats , Rats, Wistar
3.
Neuroscience ; 146(3): 1316-32, 2007 May 25.
Article in English | MEDLINE | ID: mdl-17434684

ABSTRACT

First and second generation antipsychotics (FGAs and SGAs) ameliorate psychotic symptoms of schizophrenia, however, their chronic effects on information processing and memory function (i.e. key determinants of long term functional outcome) are largely unknown. In this rodent study the effects of different time periods (ranging from 2 weeks to 6 months) of oral treatment with the FGA, haloperidol (2.0 mg/kg/day), or the SGA, risperidone (2.5 mg/kg/day) on a water maze repeated acquisition procedure, the levels of nerve growth factor receptors, and two important cholinergic proteins, the vesicular acetylcholine transporter and the high affinity choline transporter were evaluated. The effects of the antipsychotics on a spontaneous novel object recognition procedure were also assessed during days 8-14 and 31-38 of treatment. Haloperidol (but not risperidone) was associated with impairments in water maze hidden platform trial performance at each of the time periods evaluated up to 45 days, but not when tested during days 83-90. In contrast, risperidone did not impair water maze task performance at the early time periods and it was actually associated with improved performance during the 83-90 day period. Both antipsychotics, however, were associated with significant water maze impairments during the 174-180 day period. Further, haloperidol was associated with decrements in short delay performance in the spontaneous novel object recognition task during both the 8-14 and 31-38 day periods of treatment, while risperidone was associated with short delay impairment during the 31-38 day time period. Both antipsychotics were also associated with time dependent alterations in the vesicular acetylcholine transporter, the high affinity choline transporter, as well as tyrosine kinase A, and p75 neurotrophin receptors in specific brain regions. These data from rats support the notion that while risperidone may hold some advantages over haloperidol, both antipsychotics can produce time-dependent alterations in neurotrophin receptors and cholinergic proteins as well as impairments in the performance of tasks designed to assess spatial learning and episodic memory.


Subject(s)
Antipsychotic Agents/pharmacology , Haloperidol/pharmacology , Memory/drug effects , Neurons/drug effects , Parasympathetic Nervous System/drug effects , Psychomotor Performance/drug effects , Receptors, Nerve Growth Factor/biosynthesis , Risperidone/pharmacology , Animals , Enzyme-Linked Immunosorbent Assay , Hand Strength/physiology , Hippocampus/drug effects , Male , Maze Learning/drug effects , Membrane Transport Proteins/metabolism , Motor Activity/drug effects , Parasympathetic Nervous System/cytology , Postural Balance/drug effects , Rats , Rats, Wistar , Receptor, Nerve Growth Factor/biosynthesis , Receptor, trkA/metabolism , Recognition, Psychology/drug effects , Vesicular Acetylcholine Transport Proteins/metabolism
4.
Gene ; 59(1): 107-13, 1987.
Article in English | MEDLINE | ID: mdl-2830163

ABSTRACT

We present the nucleotide sequence of IS431, a new staphylococcal insertion sequence-like element flanking the mercury-resistance determinant of pI524 and associated with the methicillin-resistance determinant. IS431 left is 800 bp long and has a perfect terminal inverted repeat (IR) of 22 bp; IS431 right is 786 bp long and has a terminal IR homologous to the IR of IS431 left except that the terminal 8 bp are absent. Both IRs share a 10-bp homology with the IR of IS26 from Proteus vulgaris. No directly repeated sequences were detected immediately adjacent to the IRs. An open reading frame (ORF) of 675 bp spans most of the IS431 sequence. Its deduced amino acid (aa) sequence shows 40% homology to the 234-aa-long putative transposase coded by ORFI of IS26.


Subject(s)
DNA Transposable Elements , Proteus vulgaris/genetics , Staphylococcus aureus/genetics , Animals , Base Sequence , Cloning, Molecular , Molecular Sequence Data , Plasmids , Sequence Homology, Nucleic Acid
5.
J Hosp Infect ; 7 Suppl A: 19-27, 1986 Mar.
Article in English | MEDLINE | ID: mdl-2871094

ABSTRACT

A substantial portion of recently isolated, multiply-resistant Staphylococcus aureus was shown to carry R-determinants in plasmids. Some of these plasmids were small (3 Mdal) and carried only one R-marker. Others were 18-36 Mdal in size and carried two or more R-determinants. Several of the larger plasmids could be transferred by a conjugation-like process. The location of R-markers on transposable DNA sequences also was observed. Transposition as well as stable integration of R-plasmids into the chromosome can explain the frequent observation of chromosomal location of resistance. Chromosomal resistance might be an advantage for an organism frequently exposed to antibiotics. Molecular evidence suggests that methicillin resistance resides on additional chromosomal DNA. The organization of staphylococcal genomes as well as efficient transfer processes explain the genetic versatility of Staph. aureus, which has resulted in the development of multiply-resistant strains.


Subject(s)
Staphylococcus aureus/genetics , Anti-Bacterial Agents/pharmacology , Chromosome Mapping , DNA/analysis , Erythromycin/pharmacology , Gentamicins/pharmacology , Methicillin/pharmacology , Penicillin Resistance , Penicillinase/biosynthesis , Plasmids , Staphylococcus aureus/drug effects , Tetracycline/pharmacology
6.
J Bacteriol ; 165(2): 373-8, 1986 Feb.
Article in English | MEDLINE | ID: mdl-3003024

ABSTRACT

Additional DNA was shown to be present in methicillin-resistant Staphylococcus aureus by one- and two-dimensional restriction endonuclease analyses of the chromosomal DNA. A 3.5-kilobase Bg/II fragment, which was present in methicillin-resistant strains but not in the isogenic methicillin-sensitive parental strain, was cloned into newly constructed plasmid pWDB1 in Escherichia coli. Hybridization of this 3.5-kilobase Bg/II fragment with different methicillin-sensitive and methicillin-resistant S. aureus clinical isolates indicated that the fragment represents part of the methicillin resistance determinant (mec). In addition, the fragment carries a sequence that is present in some large staphylococcal plasmids, as well as in penicillinase plasmid pI524.


Subject(s)
Methicillin , Penicillin Resistance , Staphylococcus aureus/genetics , Chromosome Mapping , Cloning, Molecular , DNA Restriction Enzymes , DNA, Bacterial/genetics , Genes, Bacterial
SELECTION OF CITATIONS
SEARCH DETAIL
...